P

Protagonist Therapeutics
D

PTGX

88.920
USD
0.11
(0.12%)
قبل الجلسة
حجم التداول
35
الربح لكل سهم
-2
العائد الربحي
-
P/E
135
حجم السوق
5,558,893,021
أصول ذات صلة الأخبار المقالات

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.